skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Antiretroviral Agents remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines
Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines
Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines
Material Type:
Livro 		Adicionar ao Meu Espaço

Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines

World Health Organization UNAIDS,

Geneva World Health Organization 2009

Acesso online. A biblioteca também possui exemplares impressos.

2
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

Overton, Edgar T ; Richmond, Gary ; Rizzardini, Giuliano ; Jaeger, Hans ; Orrell, Catherine ; Nagimova, Firaya ; Bredeek, Fritz ; García Deltoro, Miguel ; Swindells, Susan ; Andrade-Villanueva, Jaime Federico ; Wong, Alexander ; Khuong-Josses, Marie-Aude ; Van Solingen-Ristea, Rodica ; van Eygen, Veerle ; Crauwels, Herta ; Ford, Susan ; Talarico, Christine ; Benn, Paul ; Wang, Yuanyuan ; Hudson, Krischan J ; Chounta, Vasiliki ; Cutrell, Amy ; Patel, Parul ; Shaefer, Mark ; Margolis, David A ; Smith, Kimberly Y ; Vanveggel, Simon ; Spreen, William

The Lancet (British edition), 2020-12, Vol.396 (10267), p.1994-2005 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Combination anti-HIV antibodies provide sustained virological suppression
Combination anti-HIV antibodies provide sustained virological suppression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination anti-HIV antibodies provide sustained virological suppression

Sneller, Michael C ; Blazkova, Jana ; Justement, J Shawn ; Shi, Victoria ; Kennedy, Brooke D ; Gittens, Kathleen ; Tolstenko, Jekaterina ; McCormack, Genevieve ; Whitehead, Emily J ; Schneck, Rachel F ; Proschan, Michael A ; Benko, Erika ; Kovacs, Colin ; Oguz, Cihan ; Seaman, Michael S ; Caskey, Marina ; Nussenzweig, Michel C ; Fauci, Anthony S ; Moir, Susan ; Chun, Tae-Wook

Nature (London), 2022-06, Vol.606 (7913), p.375-381 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Lockman, Shahin ; Brummel, Sean S ; Ziemba, Lauren ; Stranix-Chibanda, Lynda ; McCarthy, Katie ; Coletti, Anne ; Jean-Philippe, Patrick ; Johnston, Ben ; Krotje, Chelsea ; Fairlie, Lee ; Hoffman, Risa M ; Sax, Paul E ; Moyo, Sikhulile ; Chakhtoura, Nahida ; Stringer, Jeffrey SA ; Masheto, Gaerolwe ; Korutaro, Violet ; Cassim, Haseena ; Mmbaga, Blandina T ; João, Esau ; Hanley, Sherika ; Purdue, Lynette ; Holmes, Lewis B ; Momper, Jeremiah D ; Shapiro, Roger L ; Thoofer, Navdeep K ; Rooney, James F ; Frenkel, Lisa M ; Amico, K Rivet ; Chinula, Lameck ; Currier, Judith ; Best, Brookie M. ; Blanchette, Cheryl ; Browning, Renee ; Cheng, Yao ; Fox, Andee ; Jaliaah, Nagawa ; Knowles, Kevin ; Mirochnick, Mark ; Murtaugh, William A. ; Patras, Emmanuel ; Pinilla, Mauricio ; van Wyk, Jean ; Whalen, Frances

The Lancet (British edition), 2021-04, Vol.397 (10281), p.1276-1292 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Rizzardini, Giuliano ; Overton, Edgar T ; Orkin, Chloe ; Swindells, Susan ; Arasteh, Keikawus ; Górgolas Hernández-Mora, Miguel ; Pokrovsky, Vadim ; Girard, Pierre-Marie ; Oka, Shinichi ; Andrade-Villanueva, Jaime F ; Richmond, Gary J ; Baumgarten, Axel ; Masiá, Mar ; Latiff, Gulam ; Griffith, Sandy ; Harrington, Conn M ; Hudson, Krischan J ; St. Clair, Marty ; Talarico, Christine L ; Patel, Parul ; Cutrell, Amy ; Van Eygen, Veerle ; DʼAmico, Ronald ; Mrus, Joseph M ; Wu, Sterling ; Ford, Susan L ; Chow, Ken ; Roberts, Jeremy ; Wills, Angela ; Walters, Nicola ; Vanveggel, Simon ; Van Solingen-Ristea, Rodica ; Crauwels, Herta ; Smith, Kimberly Y ; Spreen, William R ; Margolis, David A

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (4), p.498-506 [Periódico revisado por pares]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
6
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

Molina, Jean-Michel, Dr, Prof ; Cahn, Pedro, MD ; Grinsztejn, Beatriz, MD ; Lazzarin, Adriano, Prof ; Mills, Anthony, MD ; Saag, Michael, Prof ; Supparatpinyo, Khuanchai, Prof ; Walmsley, Sharon, Prof ; Crauwels, Herta, PhD ; Rimsky, Laurence T, PhD ; Vanveggel, Simon, MSc ; Boven, Katia, MD

The Lancet (British edition), 2011-07, Vol.378 (9787), p.238-246 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Aboud, Michael ; Kaplan, Richard ; Lombaard, Johannes ; Zhang, Fujie ; Hidalgo, José A ; Mamedova, Elmira ; Losso, Marcelo H ; Chetchotisakd, Ploenchan ; Brites, Carlos ; Sievers, Jörg ; Brown, Dannae ; Hopking, Judy ; Underwood, Mark ; Nascimento, Maria Claudia ; Punekar, Yogesh ; Gartland, Martin ; Smith, Kimberly

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.253-264 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Matthews, Randolph P ; Patel, Munjal ; Barrett, Stephanie E ; Haspeslagh, Liesbeth ; Reynders, Tom ; Zhang, Saijuan ; Rottey, Sylvie ; Goodey, Adrian ; Vargo, Ryan C ; Grobler, Jay A ; Stoch, S Aubrey ; Iwamoto, Marian

Nature medicine, 2021-10, Vol.27 (10), p.1712-1717 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques

Su, Jonathan T ; Simpson, Solange M ; Sung, Samuel ; Tfaily, Ewa Bryndza ; Veazey, Ronald ; Marzinke, Mark ; Qiu, Jiang ; Watrous, David ; Widanapathirana, Lakmini ; Pearson, Elizabeth ; Peet, M Melissa ; Karunakaran, Dipu ; Grasperge, Brooke ; Dobek, Georgina ; Cain, Charlette M ; Hope, Thomas ; Kiser, Patrick F

Antimicrobial agents and chemotherapy, 2020-02, Vol.64 (3) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
10
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Cohen, Calvin J, Dr ; Andrade-Villanueva, Jaime, Prof ; Clotet, Bonaventura, MD ; Fourie, Jan, MD ; Johnson, Margaret A, Prof ; Ruxrungtham, Kiat, Prof ; Wu, Hao, MD ; Zorrilla, Carmen, MD ; Crauwels, Herta, PhD ; Rimsky, Laurence T, PhD ; Vanveggel, Simon, MSc ; Boven, Katia, MD

The Lancet (British edition), 2011-07, Vol.378 (9787), p.229-237 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (379)
  2. Livros  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2002  (7)
  2. 2002Até2006  (7)
  3. 2007Até2011  (37)
  4. 2012Até2017  (140)
  5. Após 2017  (190)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Organização Mundial da Saúde
  2. UNAIDS
  3. World Health Organization

Neste Assunto:

  1. Antiretroviral Agents
  2. Antiretroviral Agents
  3. Humans
  4. Science & Technology
  5. Hiv

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.